Does UBROGEPANT Cause Therapeutic product effect incomplete? 69 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 69 reports of Therapeutic product effect incomplete have been filed in association with UBROGEPANT (UBRELVY). This represents 2.7% of all adverse event reports for UBROGEPANT.
69
Reports of Therapeutic product effect incomplete with UBROGEPANT
2.7%
of all UBROGEPANT reports
0
Deaths
2
Hospitalizations
How Dangerous Is Therapeutic product effect incomplete From UBROGEPANT?
Of the 69 reports, 2 (2.9%) required hospitalization.
Is Therapeutic product effect incomplete Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for UBROGEPANT. However, 69 reports have been filed with the FAERS database.
What Other Side Effects Does UBROGEPANT Cause?
Drug ineffective (656)
Migraine (399)
Nausea (210)
Headache (204)
Off label use (132)
Dizziness (111)
Fatigue (92)
Somnolence (87)
Vomiting (67)
Pain (61)
What Other Drugs Cause Therapeutic product effect incomplete?
ALBUTEROL (8,496)
ADALIMUMAB (6,986)
PREDNISONE (6,709)
METHOTREXATE (6,037)
TOFACITINIB (4,914)
SECUKINUMAB (4,661)
BUDESONIDE\FORMOTEROL (4,392)
TIOTROPIUM (4,327)
MEPOLIZUMAB (4,106)
ETANERCEPT (3,961)
Which UBROGEPANT Alternatives Have Lower Therapeutic product effect incomplete Risk?
UBROGEPANT vs ULIPRISTAL
UBROGEPANT vs UMBRALISIB
UBROGEPANT vs UMECLIDINIUM
UBROGEPANT vs UMECLIDINIUM\VILANTEROL TRIFENATATE
UBROGEPANT vs UMIFENOVIR